Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
6
×
boston blog main
boston top stories
new york blog main
new york top stories
san francisco blog main
san diego blog main
san diego top stories
san francisco top stories
startups
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
boston
cancer
clinical trials
drugs
eli lilly
fda
investing
lasmiditan
migraine
teva pharmaceutical
What
drugs
6
×
new
6
×
drug
aims
medicines
neuro
research
advance
approach
approval
arguments
backed
bails
based
big
bio
biologic
biology
biotech
brand
bridgebio
called
capital
car
cause
ceo
cholesterol
class
commercialized
companies
competitors
cytokine
debuts
decades
demonstrating
develop
developing
diego’s
emerges
enhanced
Language
unset
Current search:
new
×
drugs
×
" national top stories "
×
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs